What You Should Know:
- GE HealthCare has announced the launch of its new Pristina Via™ mammography system, designed to improve the screening experience for both technologists and patients. This innovative system, debuting at the Radiological Society of North America's 2024 Annual Meeting, addresses the growing need for efficient workflows and personalized care in breast imaging.
- GE HealthCare developed Pristina Via™ based on extensive feedback from mammography technologists. The company
Read More
Breast Cancer
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France’s Largest Radiology Network
What You Should Know:
- Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
- The partnership will expand the deployment of Lunit INSIGHT MMG, an AI solution for breast cancer screening, across VIDI's extensive network of over 400 sites and 1,200 doctors.
Improving Breast Cancer Detection
Lunit INSIGHT MMG is designed to assist
Read More
Baptist Health South Florida to Deploy MICA AI’s AI-Powered Mammograms
What You Should Know:
- MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
- By integrating MICA AI's innovative technology into mammography, the collaboration aims to improve the accuracy and efficiency of breast cancer screening, leading to earlier diagnosis and better patient outcomes.
AI-Powered Mammogram Insights for Earlier Breast Cancer Detection
MICA AI, developed
Read More
Volpara Health Secures $7.3M Contract to Modernize Breast Cancer Screening for U.S. Military
What You Should Know:
- Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
- The contract will deploy Volpara's Patient Hub™ across the DHA's military health system, modernizing breast cancer screening and patient management for active-duty military personnel, retirees, and their families.
Enhancing Breast Health Management for Military
Read More
Vara Raises $8.9M to Expand AI-Powered Breast Cancer Screening Globally
What You Should Know:
- Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
- This investment, co-led by Smart Family Office, FJH, and IBB Ventures, will fuel Vara's continued expansion and its mission to revolutionize breast cancer screening through artificial intelligence.
Transforming Breast Cancer Screening with AI
Vara's AI-powered software has been shown to
Read More
LG Launches 5MP Diagnostic Monitor for Breast Imaging
What You Should Know:
- LG Electronics launches its latest addition to its diagnostic monitor lineup, the 21HQ613D-B. This 21.3-inch 5-megapixel (MP) IPS monitor has received FDA clearance for digital mammography and breast tomosynthesis.
- The new 5MP monitor is designed to improve workflow efficiency by providing healthcare professionals with the tools they need to accurately and comfortably review medical images.
Enhanced Image Quality and User Experience
The
Read More
Mika Health, AstraZeneca, and Daiichi Sankyo Partner on UNITE Program
What You Should Know:
- Mika Health, a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called "UNITE" alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo.
- The strategic initiative signifies a commitment to cross-industry collaboration to enhance the lives of cancer patients and is expected to pave the way for AI-powered solutions in other disease areas.
Mika Health: A Proven Digital Therapeutic Platform
Mika
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection
What You Should Know:
- PreciseDx®, a leader in AI-powered diagnostics for oncology, announces a crucial collaboration with UCLA's Department of Pathology and Laboratory Medicine.
- The research initiative focuses on evaluating PreciseDx's innovative tool, PreciseBreast™, for its ability to accurately assess the risk of recurrence in patients diagnosed with triple-negative breast cancer (TNBC).
Why Focus on Triple-Negative Breast Cancer?
TNBC Challenges: Accounting for
Read More
Lunit Acquires AI-Enabled Breast Cancer Detection Platform Volpara for $193M
What You Should Know:
- South Korean AI leader Lunit has announced its intention to acquire Volpara, a global pioneer in AI-powered cancer detection software, in a landmark deal worth AUD 292M (USD 193M).
- Beyond market presence, it's Volpara's deep knowledge and extensive data that truly sets it apart. With over 100 million high-quality mammogram images in its repository, Volpara offers a treasure trove of insights that will supercharge Lunit's AI capabilities and pave the way for
Read More
